The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genotyping-Global Market Insights and Sales Trends 2024
Synopsis
Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms.
The global Genotyping market size is expected to reach US$ 28170 million by 2029, growing at a CAGR of 11.4% from 2023 to 2029. The market is mainly driven by the significant applications of Genotyping in various end use industries. The expanding demands from the Pharmacogenomics, Diagnostic Research, Animal Genetics and Agricultural Biotechnology, are propelling Genotyping market. Polymerase Chain Reaction, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sequencing segment is estimated at % CAGR for the next seven-year period.
Developed regions like North America and Europe will grow comparatively slower than emerging markets like Asia-Pacific and RoW (Latin America).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genotyping, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genotyping market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genotyping market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genotyping sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genotyping covered in this report include Illumina, Affymetrix, Life Technologies, Agilent Technologies, Qiagen, Sequenom, Fluidigm, Beckman Coulter and Roche, etc.
The global Genotyping market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Affymetrix
Life Technologies
Agilent Technologies
Qiagen
Sequenom
Fluidigm
Beckman Coulter
Roche
GE Healthcare
Global Genotyping market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genotyping market, Segment by Type:
Polymerase Chain Reaction
Sequencing
Microarray
Electrophoresis
MALDI-TOF
Global Genotyping market, by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Genotyping manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Genotyping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms.
The global Genotyping market size is expected to reach US$ 28170 million by 2029, growing at a CAGR of 11.4% from 2023 to 2029. The market is mainly driven by the significant applications of Genotyping in various end use industries. The expanding demands from the Pharmacogenomics, Diagnostic Research, Animal Genetics and Agricultural Biotechnology, are propelling Genotyping market. Polymerase Chain Reaction, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sequencing segment is estimated at % CAGR for the next seven-year period.
Developed regions like North America and Europe will grow comparatively slower than emerging markets like Asia-Pacific and RoW (Latin America).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genotyping, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genotyping market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genotyping market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genotyping sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genotyping covered in this report include Illumina, Affymetrix, Life Technologies, Agilent Technologies, Qiagen, Sequenom, Fluidigm, Beckman Coulter and Roche, etc.
The global Genotyping market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Affymetrix
Life Technologies
Agilent Technologies
Qiagen
Sequenom
Fluidigm
Beckman Coulter
Roche
GE Healthcare
Global Genotyping market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genotyping market, Segment by Type:
Polymerase Chain Reaction
Sequencing
Microarray
Electrophoresis
MALDI-TOF
Global Genotyping market, by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Genotyping manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Genotyping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Genotyping Market Overview
1.1 Genotyping Product Overview
1.2 Genotyping Market Segment by Type
1.2.1 Polymerase Chain Reaction
1.2.2 Sequencing
1.2.3 Microarray
1.2.4 Electrophoresis
1.2.5 MALDI-TOF
1.3 Global Genotyping Market Size by Type
1.3.1 Global Genotyping Market Size Overview by Type (2018-2029)
1.3.2 Global Genotyping Historic Market Size Review by Type (2018-2023)
1.3.3 Global Genotyping Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Genotyping Sales Breakdown by Type (2018-2023)
1.4.2 Europe Genotyping Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Genotyping Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Genotyping Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Genotyping Sales Breakdown by Type (2018-2023)
2 Global Genotyping Market Competition by Company
2.1 Global Top Players by Genotyping Sales (2018-2023)
2.2 Global Top Players by Genotyping Revenue (2018-2023)
2.3 Global Top Players by Genotyping Price (2018-2023)
2.4 Global Top Manufacturers Genotyping Manufacturing Base Distribution, Sales Area, Product Type
2.5 Genotyping Market Competitive Situation and Trends
2.5.1 Genotyping Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Genotyping Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genotyping as of 2022)
2.7 Date of Key Manufacturers Enter into Genotyping Market
2.8 Key Manufacturers Genotyping Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Genotyping Status and Outlook by Region
3.1 Global Genotyping Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Genotyping Historic Market Size by Region
3.2.1 Global Genotyping Sales in Volume by Region (2018-2023)
3.2.2 Global Genotyping Sales in Value by Region (2018-2023)
3.2.3 Global Genotyping Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Genotyping Forecasted Market Size by Region
3.3.1 Global Genotyping Sales in Volume by Region (2024-2029)
3.3.2 Global Genotyping Sales in Value by Region (2024-2029)
3.3.3 Global Genotyping Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Genotyping by Application
4.1 Genotyping Market Segment by Application
4.1.1 Pharmacogenomics
4.1.2 Diagnostic Research
4.1.3 Animal Genetics
4.1.4 Agricultural Biotechnology
4.2 Global Genotyping Market Size by Application
4.2.1 Global Genotyping Market Size Overview by Application (2018-2029)
4.2.2 Global Genotyping Historic Market Size Review by Application (2018-2023)
4.2.3 Global Genotyping Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Genotyping Sales Breakdown by Application (2018-2023)
4.3.2 Europe Genotyping Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Genotyping Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Genotyping Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Genotyping Sales Breakdown by Application (2018-2023)
5 North America Genotyping by Country
5.1 North America Genotyping Historic Market Size by Country
5.1.1 North America Genotyping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Genotyping Sales in Volume by Country (2018-2023)
5.1.3 North America Genotyping Sales in Value by Country (2018-2023)
5.2 North America Genotyping Forecasted Market Size by Country
5.2.1 North America Genotyping Sales in Volume by Country (2024-2029)
5.2.2 North America Genotyping Sales in Value by Country (2024-2029)
6 Europe Genotyping by Country
6.1 Europe Genotyping Historic Market Size by Country
6.1.1 Europe Genotyping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Genotyping Sales in Volume by Country (2018-2023)
6.1.3 Europe Genotyping Sales in Value by Country (2018-2023)
6.2 Europe Genotyping Forecasted Market Size by Country
6.2.1 Europe Genotyping Sales in Volume by Country (2024-2029)
6.2.2 Europe Genotyping Sales in Value by Country (2024-2029)
7 Asia-Pacific Genotyping by Region
7.1 Asia-Pacific Genotyping Historic Market Size by Region
7.1.1 Asia-Pacific Genotyping Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Genotyping Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Genotyping Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Genotyping Forecasted Market Size by Region
7.2.1 Asia-Pacific Genotyping Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Genotyping Sales in Value by Region (2024-2029)
8 Latin America Genotyping by Country
8.1 Latin America Genotyping Historic Market Size by Country
8.1.1 Latin America Genotyping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Genotyping Sales in Volume by Country (2018-2023)
8.1.3 Latin America Genotyping Sales in Value by Country (2018-2023)
8.2 Latin America Genotyping Forecasted Market Size by Country
8.2.1 Latin America Genotyping Sales in Volume by Country (2024-2029)
8.2.2 Latin America Genotyping Sales in Value by Country (2024-2029)
9 Middle East and Africa Genotyping by Country
9.1 Middle East and Africa Genotyping Historic Market Size by Country
9.1.1 Middle East and Africa Genotyping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Genotyping Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Genotyping Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Genotyping Forecasted Market Size by Country
9.2.1 Middle East and Africa Genotyping Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Genotyping Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Illumina
10.1.1 Illumina Company Information
10.1.2 Illumina Introduction and Business Overview
10.1.3 Illumina Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Illumina Genotyping Products Offered
10.1.5 Illumina Recent Development
10.2 Affymetrix
10.2.1 Affymetrix Company Information
10.2.2 Affymetrix Introduction and Business Overview
10.2.3 Affymetrix Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Affymetrix Genotyping Products Offered
10.2.5 Affymetrix Recent Development
10.3 Life Technologies
10.3.1 Life Technologies Company Information
10.3.2 Life Technologies Introduction and Business Overview
10.3.3 Life Technologies Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Life Technologies Genotyping Products Offered
10.3.5 Life Technologies Recent Development
10.4 Agilent Technologies
10.4.1 Agilent Technologies Company Information
10.4.2 Agilent Technologies Introduction and Business Overview
10.4.3 Agilent Technologies Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Agilent Technologies Genotyping Products Offered
10.4.5 Agilent Technologies Recent Development
10.5 Qiagen
10.5.1 Qiagen Company Information
10.5.2 Qiagen Introduction and Business Overview
10.5.3 Qiagen Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Qiagen Genotyping Products Offered
10.5.5 Qiagen Recent Development
10.6 Sequenom
10.6.1 Sequenom Company Information
10.6.2 Sequenom Introduction and Business Overview
10.6.3 Sequenom Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sequenom Genotyping Products Offered
10.6.5 Sequenom Recent Development
10.7 Fluidigm
10.7.1 Fluidigm Company Information
10.7.2 Fluidigm Introduction and Business Overview
10.7.3 Fluidigm Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Fluidigm Genotyping Products Offered
10.7.5 Fluidigm Recent Development
10.8 Beckman Coulter
10.8.1 Beckman Coulter Company Information
10.8.2 Beckman Coulter Introduction and Business Overview
10.8.3 Beckman Coulter Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Beckman Coulter Genotyping Products Offered
10.8.5 Beckman Coulter Recent Development
10.9 Roche
10.9.1 Roche Company Information
10.9.2 Roche Introduction and Business Overview
10.9.3 Roche Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Roche Genotyping Products Offered
10.9.5 Roche Recent Development
10.10 GE Healthcare
10.10.1 GE Healthcare Company Information
10.10.2 GE Healthcare Introduction and Business Overview
10.10.3 GE Healthcare Genotyping Sales, Revenue and Gross Margin (2018-2023)
10.10.4 GE Healthcare Genotyping Products Offered
10.10.5 GE Healthcare Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Genotyping Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Genotyping Industrial Chain Analysis
11.4 Genotyping Market Dynamics
11.4.1 Genotyping Industry Trends
11.4.2 Genotyping Market Drivers
11.4.3 Genotyping Market Challenges
11.4.4 Genotyping Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Genotyping Distributors
12.3 Genotyping Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
